Welcome to our dedicated page for Curaleaf Hldgs news (Ticker: CURLF), a resource for investors and traders seeking the latest updates and insights on Curaleaf Hldgs stock.
Curaleaf Holdings, Inc. (OTCQX: CURLF, TSX: CURA) generates frequent news as an international provider of consumer cannabis products operating across medical and adult-use markets. Company updates often highlight its portfolio of brands, including Curaleaf, Select, Grassroots, Find, Anthem and The Hemp Company, and how these brands are deployed through retail dispensaries and international channels.
News coverage for Curaleaf commonly includes corporate and regulatory developments, such as its announced intention to seek shareholder approval for a proposed arrangement to continue from British Columbia, Canada to Delaware in the United States. This proposed domestication is described by the company as a way to align its corporate structure with its operational focus while maintaining its listings on the Toronto Stock Exchange and OTCQX.
Investors and observers can also expect retail expansion and operational updates. Recent announcements have covered the opening and relocation of dispensaries, including Curaleaf Millcreek in Erie, Pennsylvania, and Curaleaf Cape Canaveral in Florida. These releases describe new store locations, in-store experience, and the availability of products such as premium flower, vapes and edibles under the company’s brands.
Curaleaf’s news flow further includes transaction and financing announcements, such as its binding commitment to acquire, and later the termination of that commitment for, The Cannabist Company’s Virginia assets, and the upsizing of its revolving credit facility with Needham Bank from $40 million to $100 million. In addition, the company issues financial results releases, including quarterly reports prepared under U.S. GAAP that detail segment revenue, margins, cash flow and non-GAAP performance measures.
Beyond financial and operational items, Curaleaf also reports on community and social initiatives like its Feed the Block fundraiser to address food insecurity and partnerships with organizations such as the Baldwin Fund. For those tracking CURLF, this news page brings together these various categories of updates in one place.
Curaleaf Holdings announced participation in key investor conferences in January 2022. Notable events include the ICR Conference on January 10, featuring Executive Vice Chairman Joseph Lusardi, and the 24th Annual Needham Virtual Growth Conference on January 12, with Executive Chairman Boris Jordan.
Additionally, CEO Joe Bayern will participate in the ATB's 10th Annual Institutional Conference on January 13. Curaleaf operates 117 dispensaries and 25 cultivation sites across 23 U.S. states, and is recognized as a major player in the cannabis sector, aiming to enhance consumer confidence and clarity around cannabis.
Curaleaf Holdings, Inc. announced the appointment of Matt Darin as President, effective immediately, to enhance organizational efficiency during a period of significant growth. Darin, the former COO of Grassroots Cannabis, has extensive industry experience and will report to CEO Joseph Bayern. The company is undergoing strategic acquisitions including Los Suenos Farms and Bloom Dispensaries. Additionally, COO Neil Davidson is retiring effective January 3, 2022, but will assist during the transition until March 31, 2022. Curaleaf continues to expand its operations across 23 states.
Curaleaf has announced its acquisition of Bloom Dispensaries for approximately US$211 million, enhancing its operational presence in Arizona. This cash transaction, set to close in January 2022, will increase Curaleaf's Arizona dispensary count to 16 and expand its footprint to 128 retail locations nationwide.
The acquisition is projected to be immediately accretive to Curaleaf's adjusted EBITDA margins, with Bloom generating 2021 revenues of around US$66 million and boasting more than 40% EBITDA margins.
Curaleaf announced its tenth dispensary in Arizona, acquiring Natural Remedy Patient Center for approximately US$13 million. This cash and stock transaction will close in January 2022, increasing Curaleaf's retail footprint to 118 dispensaries across the U.S. The existing Safford location will be relocated to a new, flagship 9,000 square foot dispensary in Scottsdale, enhancing visibility at a high-traffic site. The company emphasizes its strategy to expand its U.S. presence through acquisitions and organic growth.
Curaleaf Holdings, Inc. (CSE: CURA / OTCQX: CURLF) is set to enhance its retail presence in Florida by opening four new dispensaries by year-end 2021. With this expansion, the company will operate a total of 42 dispensaries in Florida and 117 nationwide. The first location, Curaleaf Stuart, is now open, followed by three others in Lady Lake, Wesley Chapel, and Miami. Curaleaf has doubled its Florida market share to 15% this year, attributed to increased product innovation and retail accessibility. Grand opening events are scheduled for January 8, 2022.
Curaleaf Holdings (CURLF) announced the launch of Select X Bites, a new edible cannabis product designed for faster onset, stronger effects, and longer-lasting experiences. Utilizing innovative encapsulation technology, each 10mg THC bite is aimed at seasoned users and is initially available in states like Arizona, Maine, Colorado, and Nevada, with expansion planned for Massachusetts, Michigan, California, and Maryland. This product follows a series of new offerings from Select, focusing on consumer preferences and advanced cannabis experiences.
Curaleaf and B NOBLE have expanded their partnership into medical dispensaries in New York. This initiative marks a significant milestone in advancing social equity in the cannabis industry. The New York Cannabis Control Board recently approved whole flower cannabis offerings. B NOBLE, co-founded by Bernard Noble, aims to support those affected by the War on Drugs. The brand will introduce whole flower products in New York, with 10% of proceeds dedicated to local organizations focused on social equity. B NOBLE is now available in ten states, highlighting its growth and commitment to social impact.
Curaleaf Holdings, Inc. (CSE: CURA / OTCQX: CURLF) announces the opening of its 38th dispensary in Florida, located in Spring Hill. This marks Curaleaf's expansion in the state, bringing its total to 113 nationwide dispensaries. The Spring Hill location will offer high-quality medical cannabis products, including Select and new releases like Select Squeeze and Select Bites. To celebrate the grand opening on December 4th, patients can enjoy a 30% discount on most products. Curaleaf has also created over 1,000 jobs in Florida in 2021, enhancing local access to cannabis care.
Curaleaf has announced the opening of its new dispensary, Curaleaf 48th Street, in Phoenix, Arizona, marking the company’s ninth location in the state and 112th nationwide. The facility, spanning 5,000 square feet, will operate seven days a week and create over 40 new jobs in the local economy. Following the legalization of adult-use cannabis in January, Curaleaf has reported an 80% increase in customer demand. The grand opening event is scheduled from December 3 to December 5, featuring promotional offers for first-time visitors.
Curaleaf Holdings has established a national distribution agreement with Southern Glazer's Wine & Spirits, enhancing the reach of its Hemp and Select CBD product lines. This collaboration leverages Curaleaf's high-quality non-psychoactive hemp expertise alongside Southern Glazer's extensive distribution network and e-commerce platform. The partnership aims to drive growth and innovation in Curaleaf's CBD offerings, including new products featuring minor cannabinoids. Curaleaf operates across 23 U.S. states, with over 111 dispensaries, and is committed to quality and customer accessibility.